Why it Matters to Patients

Diabetes is the 7th leading cause of death, and a major cause of heart attacks, strokes, and blindness globally. Adults with diabetes are 2 or 3 times more likely to have a stroke or heart attack.

Why they came to us

New indications for SGLT2 inhibitors have greatly disrupted the traditional diabetes market requiring our client to build new strategies and tactics to defend and grow their position in the market.

What we did

Our DARWEN™ technology extracted information from patients suffering from both cardiovascular disease and diabetes, and provided the following insights:

Lung Cancer
Heart Failure
Mental Health